USPSTF Recommends HIV Screening for Adolescents and Adults Ages 15-65
The USPSTF gave an "A" rated recommendation for clinicians to screen all adolescents and adults ages 15-65 for HIV, making it an essential health benefit under the Affordable Care Act.
OraQuick ADVANCE® Webinar
- New FDA-approved performance data
- Compare results from new OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test to third-generation automated EIA's
- Discuss benefits of utilizing a rapid point-of-care test for HIV
- Discuss benefits of the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
3rd Generation Detection of IgM Antibodies
At OraSure Technologies, we recognize the importance of HIV test and ensuring that infected people get diagnosed early and linked to care. It is a well known fact that early HIV diagnosis improves patient health outcomes while preventing new infections.
OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test now delivers earlier antibody sensitivity. Our new materials and process improvements have gained critical detection days from initial infection including IgM anti-HIV-1 reactivity and demonstrated 3rd generation automated EIAs sensitivity.
OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test now delivers earlier antibody sensitivity. Our new materials and process improvements have gained critical detection days from initial infection including IgM anti-HIV-1 reactivity and demonstrated 3rd generation automated EIAs sensitivity.
Accuracy.
Versatility.
Reliability.
Partners for HIV Testing:
